PRKAA1 and metabolic dysfunction-associated steatotic liver disease: Studies indicated that mammalian STE20-Like Kinase 1 deletion alleviates renal ischemia-reperfusion injury and non-alcoholic fatty liver disease via modulating mitophagy and the AMPK signaling pathway [51,52].